Why Chinese biotech inventions have yet to make an impact globally, despite patenting surge 07 Aug 18
A new academic article about patenting in the BRICS countries makes fascinating reading for life sciences IP professionals interested in gauging the development and current state of China’s biotechnology patent landscape.
Want to read more?
Register to access two of our subscriber-only articles per month
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts
What our customers are saying
One of the advantages of IAM is that it is high quality and yet still accessible and relevant to the non-specialist chief executives and senior managers who don't know what they don't know about IP. It's an important contribution to the upward IP education of senior managers.
International Intellectual Property Strategists Association (INTIPSA)
Subscribe to receive access to the full range of premium business intelligence, insights and analysis, as well as our IP directories, guides and daily news.
Register for more free content
- Read more IAM blogs and articles
- Receive the editor's weekly review by email